Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of 2026-04-29, Terns Pharmaceuticals Inc. (TERN) trades at a current price of $52.92, marking a negligible -0.04% change from the prior session’s close. This analysis explores recent market context for the clinical-stage biopharmaceutical firm, key technical price levels, and potential near-term price scenarios, with no recently released earnings data available for the company as of this writing. Price action for TERN in recent weeks has been largely range-bound, driven primarily by broader h
What closed end fund Terns Pharmaceuticals (TERN)? (Motionless) 2026-04-29 - Real Time Stock Idea Network
TERN - Stock Analysis
3818 Comments
897 Likes
1
Daliyah
Consistent User
2 hours ago
Anyone else confused but still here?
👍 83
Reply
2
Bronte
Registered User
5 hours ago
Missed the perfect timing…
👍 185
Reply
3
Travyon
Legendary User
1 day ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
👍 294
Reply
4
Burris
Daily Reader
1 day ago
Really missed out… oof. 😅
👍 249
Reply
5
Kaiza
New Visitor
2 days ago
I feel like I should take notes… but won’t.
👍 284
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.